(Total Views: 290)
Posted On: 10/22/2020 10:05:47 AM
Post# of 63

$BPTH News Article - Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogues or Bcr-Abl Tyrosine Kinase Inhibitors in a Variety of Cancers https://marketwirenews.com/news-releases/bio-...58946.html


My Twitter: WhyteStocks